PTCT
PTC THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$68.97
+1.25%Forward multiples
Based on analyst estimates
- P/E forward
- 36.63x
- P/E 2026E
- 130.36x
- P/E 2027E
- 25.12x
- P/E 2028E
- 15.85x
- P/S forward
- 4.40x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -30.13x
- Price / sales
- 4.99x
- Price / cash flow
- 549.45x
Enterprise value
- Enterprise value
- $4.3B
- EV / sales
- 3.70x
- EV / EBITDA
- 24.47x
- EV / EBIT
- 30.86x
- Market cap
- $5.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026